Stephanie L Thorn1,2, Shayne C Barlow3, Attila Feher1,2, Mitchel R Stacy1,2, Heather Doviak3, Julia Jacobs3, Kia Zellars3, Jennifer M Renaud4, Ran Klein4, Robert A deKemp4, Aarif Y Khakoo5, TaeWeon Lee5, Francis G Spinale3, Albert J Sinusas1,6,2. 1. Section of Cardiovascular Medicine, Department of Internal Medicine (S.L.T., A.F., M.R.S., A.J.S.), Yale University, School of Medicine, New Haven, CT. 2. Yale Translational Research Imaging Center, Department of Internal Medicine, New Haven, CT (S.L.T., A.F., M.R.S., A.J.S.). 3. Department of Cell Biology and Anatomy, Surgery, Cardiovascular Translational Research Center, WJB Dorn Veteran Affairs Medical Center, University of South Carolina School of Medicine, Columbia (S.C.B., H.D., J.J., K.Z., F.G.S.). 4. Division of Cardiology, University of Ottawa Heart Institute, ON, Canada (J.M.R., R.K., R.dK.). 5. Amgen, CardioMetabolic Disorders, South San Francisco, CA (A.Y.K., T.W.). 6. Department of Radiology and Biomedical Imaging (A.J.S.), Yale University, School of Medicine, New Haven, CT.
Abstract
BACKGROUND: The induction of matrix metalloproteinases (MMPs) and reduction in tissue inhibitors of MMPs (TIMPs) plays a role in ischemia/reperfusion (I/R) injury post-myocardial infarction (MI) and subsequent left ventricular remodeling. We developed a hybrid dual isotope single-photon emission computed tomography/computed tomography approach for noninvasive evaluation of regional myocardial MMP activation with 99mTc-RP805 and dynamic 201Tl for determination of myocardial blood flow, to quantify the effects of intracoronary delivery of recombinant TIMP-3 (rTIMP-3) on I/R injury. METHODS: Studies were performed in control pigs (n=5) and pigs following 90-minute balloon occlusion-induced ischemia/reperfusion (I/R) of left anterior descending artery (n=9). Before reperfusion, pigs with I/R were randomly assigned to intracoronary infusion of rTIMP-3 (1.0 mg/kg; n=5) or saline (n=4). Three days post-I/R, dual isotope imaging was performed with 99mTc-RP805 and 201Tl along with contrast cineCT to assess left ventricular function. RESULTS: The ischemic to nonischemic ratio of 99mTc-RP805 was significantly increased following I/R in saline group (4.03±1.40), and this ratio was significantly reduced with rTIMP-3 treatment (2.22±0.57; P=0.03). This reduction in MMP activity in the MI-rTIMP-3 treatment group was associated with an improvement in relative MI region myocardial blood flow compared with the MI-saline group and improved myocardial strain in the MI region. CONCLUSIONS: We have established a novel hybrid single-photon emission computed tomography/computed tomography imaging approach for the quantitative assessment of regional MMP activation, myocardial blood flow, and cardiac function post-I/R that can be used to evaluate therapeutic interventions such as intracoronary delivery of rTIMP-3 for reduction of I/R injury in the early phases of post-MI remodeling.
BACKGROUND: The induction of matrix metalloproteinases (MMPs) and reduction in tissue inhibitors of MMPs (TIMPs) plays a role in ischemia/reperfusion (I/R) injury post-myocardial infarction (MI) and subsequent left ventricular remodeling. We developed a hybrid dual isotope single-photon emission computed tomography/computed tomography approach for noninvasive evaluation of regional myocardial MMP activation with 99mTc-RP805 and dynamic 201Tl for determination of myocardial blood flow, to quantify the effects of intracoronary delivery of recombinant TIMP-3 (rTIMP-3) on I/R injury. METHODS: Studies were performed in control pigs (n=5) and pigs following 90-minute balloon occlusion-induced ischemia/reperfusion (I/R) of left anterior descending artery (n=9). Before reperfusion, pigs with I/R were randomly assigned to intracoronary infusion of rTIMP-3 (1.0 mg/kg; n=5) or saline (n=4). Three days post-I/R, dual isotope imaging was performed with 99mTc-RP805 and 201Tl along with contrast cineCT to assess left ventricular function. RESULTS: The ischemic to nonischemic ratio of 99mTc-RP805 was significantly increased following I/R in saline group (4.03±1.40), and this ratio was significantly reduced with rTIMP-3 treatment (2.22±0.57; P=0.03). This reduction in MMP activity in the MI-rTIMP-3 treatment group was associated with an improvement in relative MI region myocardial blood flow compared with the MI-saline group and improved myocardial strain in the MI region. CONCLUSIONS: We have established a novel hybrid single-photon emission computed tomography/computed tomography imaging approach for the quantitative assessment of regional MMP activation, myocardial blood flow, and cardiac function post-I/R that can be used to evaluate therapeutic interventions such as intracoronary delivery of rTIMP-3 for reduction of I/R injury in the early phases of post-MI remodeling.
Authors: Wenjie Wang; Costas J Schulze; Wilma L Suarez-Pinzon; Jason R B Dyck; Grzegorz Sawicki; Richard Schulz Journal: Circulation Date: 2002-09-17 Impact factor: 29.690
Authors: R Glenn Wells; Rachel Timmins; Ran Klein; Julia Lockwood; Brian Marvin; Robert A deKemp; Lihui Wei; Terrence D Ruddy Journal: J Nucl Med Date: 2014-09-04 Impact factor: 10.057
Authors: C B Xue; M E Voss; D J Nelson; J J Duan; R J Cherney; I C Jacobson; X He; J Roderick; L Chen; R L Corbett; L Wang; D T Meyer; K Kennedy; W F DeGradodagger; K D Hardman; C A Teleha; B D Jaffee; R Q Liu; R A Copeland; M B Covington; D D Christ; J M Trzaskos; R C Newton; R L Magolda; R R Wexler; C P Decicco Journal: J Med Chem Date: 2001-08-02 Impact factor: 7.446
Authors: Santhosh K Mani; Christine B Kern; Denise Kimbrough; Benjamin Addy; Harinath Kasiganesan; William T Rivers; Risha K Patel; James C Chou; Francis G Spinale; Rupak Mukherjee; Donald R Menick Journal: Am J Physiol Heart Circ Physiol Date: 2015-03-20 Impact factor: 4.733
Authors: Franca S Angeli; Mia Shapiro; Nicolas Amabile; Gina Orcino; Charles S Smith; Theresa Tacy; Andrew J Boyle; Kanu Chatterjee; Stanton A Glantz; William Grossman; Yerem Yeghiazarians Journal: Comp Med Date: 2009-06 Impact factor: 0.982
Authors: Stephanie L Thorn; James A Shuman; Mitchel R Stacy; Brendan P Purcell; Heather Doviak; Jason A Burdick; Francis G Spinale; Albert J Sinusas Journal: J Cardiovasc Transl Res Date: 2022-06-13 Impact factor: 4.132
Authors: Mitchel R Stacy; Ben A Lin; Stephanie L Thorn; David C Lobb; Mark W Maxfield; Craig Novack; Kia N Zellars; Lisa Freeburg; Joseph G Akar; Albert J Sinusas; Francis G Spinale Journal: Heart Rhythm Date: 2022-01-21 Impact factor: 6.779
Authors: Stefan Frantz; Moritz Jens Hundertmark; Jeanette Schulz-Menger; Frank Michael Bengel; Johann Bauersachs Journal: Eur Heart J Date: 2022-07-14 Impact factor: 35.855